Revitsky A R, Klein L C
Department of Biobehavioral Health, 219 Biobehavioral Health Building, The Pennsylvania State University, University Park, PA 16802, USA.
Curr Drug Abuse Rev. 2013 Sep;6(3):231-44. doi: 10.2174/1874473707666140205200532.
Ghrelin is a gut-brain hormone that regulates energy balance through food consumption. While ghrelin is well known for its role in hypothalamic activation and homeostatic feeding, more recent evidence suggests that ghrelin also is involved in hedonic feeding through the dopaminergic reward pathway. This paper investigated how ghrelin administration (intraperitoneal, intracerebroventricular, or directly into dopaminergic reward-relevant brain regions) activates the dopaminergic reward pathway and associated reward-relevant behavioral responses in rodents. A total of 19 empirical publications that examined one or more of these variables were included in this review. Overall, ghrelin administration increases dopamine levels in the nucleus accumbens, as well as reward-relevant behaviors such as food (both standard chow and palatable foods) and alcohol consumption. Ghrelin administration also increases operant responding for sucrose, and conditioned place preference. Following a review of the small body of literature examining the effects of ghrelin administration on the dopamine reward pathway, we present a model of the relationship between ghrelin and dopaminergic reward activation. Specifically, ghrelin acts on ghrelin receptors (GHS-R1A) in the ventral tegmental area (VTA) and lateral dorsal tegmental nucleus (LDTg) to stimulate the mesolimbic dopamine reward pathway, which results in increased rewarding behaviors in rodents. Results from this review suggest that selective antagonism of the ghrelin system may serve as potential treatment for addictive drug use. This review highlights gaps in the literature, including a lack of examination of sex- or age-related differences in the effects of ghrelin on dopamine reward processes. In light of vulnerability to drug abuse among female and adolescent populations, future studies should target these individual difference factors.
胃饥饿素是一种肠脑激素,通过食物摄入来调节能量平衡。虽然胃饥饿素因其在下丘脑激活和稳态进食中的作用而广为人知,但最近的证据表明,胃饥饿素还通过多巴胺能奖赏通路参与享乐性进食。本文研究了给予胃饥饿素(腹腔内、脑室内或直接注入与多巴胺能奖赏相关的脑区)如何激活啮齿动物的多巴胺能奖赏通路以及相关的奖赏相关行为反应。本综述共纳入了19篇研究上述一个或多个变量的实证性出版物。总体而言,给予胃饥饿素会增加伏隔核中的多巴胺水平,以及与奖赏相关的行为,如食物(标准饲料和美味食物)摄入和酒精消费。给予胃饥饿素还会增加对蔗糖的操作性反应以及条件性位置偏爱。在回顾了少量研究给予胃饥饿素对多巴胺奖赏通路影响的文献后,我们提出了胃饥饿素与多巴胺能奖赏激活之间关系的模型。具体而言,胃饥饿素作用于腹侧被盖区(VTA)和外侧背被盖核(LDTg)中的胃饥饿素受体(GHS-R1A),以刺激中脑边缘多巴胺奖赏通路,从而导致啮齿动物的奖赏行为增加。本综述结果表明,胃饥饿素系统的选择性拮抗作用可能是治疗成瘾性药物使用的潜在方法。本综述突出了文献中的空白,包括缺乏对胃饥饿素对多巴胺奖赏过程影响的性别或年龄相关差异的研究。鉴于女性和青少年人群易患药物滥用问题,未来研究应针对这些个体差异因素。